Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Heinen currently holds 60,919 shares of Better Therapeutics, Inc. (BTTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Heinen has been a net buyer of BTTX stock. They have purchased $141.9K and sold $0 worth of shares.
Mark Heinen's most recent insider trade was on Mar 27, 2026, when they sold 10,000 shares at $0.26 per share.
Mark Heinen serves as Executive at Better Therapeutics, Inc. (BTTX). They have executed 15 insider transactions totaling $141.9K over their tenure at the company.
Mark Heinen holds the position of Executive at Better Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mark Heinen has shown a buying trading pattern, with $141.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Heinen was on Sep 13, 2022, when they purchased $50.7K worth of BTTX shares. This transaction involved 26,132 shares at $1.94 per share.
Mark Heinen currently owns 60,919 shares of Better Therapeutics, Inc. (BTTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Heinen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Heinen has 15 Form 4 filings on record as an insider at Better Therapeutics, Inc..
Set alerts for Mark Heinen and 40,000+ other insiders.